The burden of diseases and risk factors in Bangladesh, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
- PMID: 37973341
- PMCID: PMC10664824
- DOI: 10.1016/S2214-109X(23)00432-1
The burden of diseases and risk factors in Bangladesh, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
Abstract
Background: Bangladesh has made substantial progress in improving socioeconomic and health indicators over the past 50 years, but data on national disease burden are scarce. We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to estimate the burden of diseases and risk factors in Bangladesh from 1990 to 2019.
Methods: For this systematic analysis, we analysed data from vital registration systems, surveys, and censuses using multistage modelling processes to estimate life expectancy at birth, mortality rate, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs). Additionally, we compared the health status of Bangladesh with that of the other countries in the GBD south Asia region-Bhutan, India, Nepal, and Pakistan.
Findings: Life expectancy at birth in Bangladesh increased from 58·2 years (95% uncertainty interval 57·1-59·2) in 1990 to 74·6 years (72·4-76·7) in 2019. Between 1990 and 2019, the age-standardised mortality rate decreased from 1509·3 (1428·6-1592·1) to 714·4 (604·9-838·2) deaths per 100 000 population. In 2019, non-communicable diseases represented 14 of the top 20 causes of death; the leading three causes were stroke, ischaemic heart disease, and chronic obstructive pulmonary disease. High blood pressure, high fasting plasma glucose, and smoking were the top three risk factors. From 1990 to 2019, the rate of all-cause DALYs decreased by 54·9% (48·8-60·4). In 2019, the leading causes of DALYs and YLLs were neonatal disorders, stroke, and ischaemic heart disease, whereas musculoskeletal disorders, depressive disorders, and low back pain were the leading causes of YLDs. Bangladesh has the lowest age-standardised rates of mortality, YLDs, and YLLs and the highest life expectancy at birth in south Asia.
Interpretation: Over the past 30 years, mortality rates have reduced by more than half in Bangladesh. Bangladesh must now address the double burden of communicable and non-communicable diseases. Cost-effective, multisectoral efforts are needed to prevent and control non-communicable diseases, promote healthy lifestyles, and prevent premature mortality and disabilities.
Funding: Bill & Melinda Gates Foundation.
Translation: For the Bangla translation of the abstract see Supplementary Materials section.
Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests S M S Islam reports support for this manuscript from an Emerging Leadership Fellowship from the National Health and Medical Research Council of Australia (APP1195406) and Vanguard grants from the National Heart Foundation of Australia. S M S Islam has unpaid roles, outside the submitted work, with the IT Committee of the Cardiac Society of Australia and New Zealand, as a volunteer on the Cardiac Devices Committee of the ESC Heart Failure Association, and as a volunteer topic group leader for the WHO-ITU Global Initiative on AI for Health. K M Livingstone reports support for this manuscript from a National Health and Medical Research Council of Australia grant (APP1173803).
Figures


Comment in
-
Sustaining progress in the health landscape of Bangladesh.Lancet Glob Health. 2023 Dec;11(12):e1838-e1839. doi: 10.1016/S2214-109X(23)00494-1. Lancet Glob Health. 2023. PMID: 37973328 No abstract available.
Similar articles
-
Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021.Lancet Gastroenterol Hepatol. 2024 Sep;9(9):825-858. doi: 10.1016/S2468-1253(24)00157-2. Epub 2024 Jul 17. Lancet Gastroenterol Hepatol. 2024. PMID: 39032499 Free PMC article.
-
Disability-adjusted life years, years lived with disability, and years of life lost of diseases among children and adolescents in national and subnational levels of Iran, 1990-2021: A systematic analysis for the Global Burden of Disease 2021.PLoS One. 2025 Jun 23;20(6):e0325085. doi: 10.1371/journal.pone.0325085. eCollection 2025. PLoS One. 2025. PMID: 40549740 Free PMC article.
-
Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet Neurol. 2024 Oct;23(10):973-1003. doi: 10.1016/S1474-4422(24)00369-7. Lancet Neurol. 2024. PMID: 39304265 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Beta-blockers in patients without heart failure after myocardial infarction.Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2. Cochrane Database Syst Rev. 2021. PMID: 34739733 Free PMC article.
Cited by
-
Designing Front-of-Package Labels to Inform Consumers and Encourage Healthier Food Choices in Bangladesh: A Qualitative Study.Nutrients. 2024 Nov 21;16(23):3989. doi: 10.3390/nu16233989. Nutrients. 2024. PMID: 39683383 Free PMC article.
-
Lipid-Derived Biomarkers as Therapeutic Targets for Chronic Coronary Syndrome and Ischemic Stroke: An Updated Narrative Review.Medicina (Kaunas). 2024 Mar 29;60(4):561. doi: 10.3390/medicina60040561. Medicina (Kaunas). 2024. PMID: 38674207 Free PMC article. Review.
-
Burden of non-communicable diseases in South Asia: a decomposition analysis.J Health Popul Nutr. 2025 Apr 18;44(1):124. doi: 10.1186/s41043-025-00827-0. J Health Popul Nutr. 2025. PMID: 40251654 Free PMC article.
-
Burden and Predictors of Statin Use for Primary and Secondary Prevention of Cardiovascular Disease in Bangladesh: Evidence from a Nationally Representative Survey.Glob Heart. 2025 Mar 12;20(1):28. doi: 10.5334/gh.1412. eCollection 2025. Glob Heart. 2025. PMID: 40094069 Free PMC article.
-
Assessing community antibiotic usage and adherence as per standard treatment guidelines: A potential area to enhance awareness at community pharmacy settings.Explor Res Clin Soc Pharm. 2024 Dec 12;17:100552. doi: 10.1016/j.rcsop.2024.100552. eCollection 2025 Mar. Explor Res Clin Soc Pharm. 2024. PMID: 39811094 Free PMC article.
References
-
- World Population Review Bangladesh Population 2023. 2023. https://worldpopulationreview.com/countries/bangladesh-population
-
- The World Bank The World Bank in Bangladesh. 2023. https://www.worldbank.org/en/country/bangladesh/overview#1
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous